Catalyst Pharmaceuticals Inc. closed 5.04% below its 52-week high of $26.16, which the company reached on March 24th.

Shares of Regeneron Pharmaceuticals Inc. REGN rallied 2.65% to $605.61 Friday, on what proved to be an all-around favorable ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients ...

"The strong global launch of YORVIPATH positions 2025 to be an inflection point for Ascendis with growing revenue and a path ...

The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Many Medicare recipients are benefiting from changes that make prescriptions more affordable. But you can still make other ...

Walmart Canada is proud to announce the opening of its first pharmacy clinic today in St. Catharines, Ontario, with additional clinics opening later this year. The new in-store clinic space will ...

Arbor Scientia Group has been recognized by Pharma Tech Outlook as a Top Veeva Solutions Provider 2025. Arbor Scientia Group ...

Sumitomo Pharma America, Inc. (SMPA) presented new, positive data from the COURAGE Phase 3 open-label extension study of vibegron (GEMTESA®) in men living with overactive bladder (OAB) and receiving ...

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000-until recently.

Boynton led the Civil Division’s roughly 1,100 attorneys from January 2021 to January 2025, serving as principal deputy ...